Topic
340B
257 published works
Health Industry Washington Watch
OIG Faults State Efforts to Identify 340B Drug Claims; Cites Risk of Duplicate Discounts, Forgone Rebates
The OIG recently examined how states that pay for drugs through Medicaid managed care organizations (MCOs) identify and exclude 340B drug claims when collecting Medicaid rebates, since states are prohibited…
Capital Thinking
Ways and Means Committee to Consider Proposals to Advance Hospital Reforms and Improve TANF; HRSA Delays the Release of 340B Rules
Legislative Activity Ways and Means Committee to Consider Proposals to Advance Hospital Reforms and Improve TANF On Tuesday, May 24, the House Committee on Ways and Means will continue their…
Health Law Update
HHS Reopens Comment Period for Proposed Rule on 340B Drug Program
The U.S. Department of Health and Human Services (HHS) is reopening the comment period for the proposed rule titled “340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation.” HHS…
Inside Government Contracts
HRSA Seeks a Second Round of Comments on 340B Penny Pricing, New Drug Estimates, and Civil Monetary Penalties
On Monday, April 18th, the Health Resources and Services Administration (“HRSA”) and the Department of Health and Human Services (“HHS”) reopened the comment period for their proposed rule “340B Drug…
Health Industry Washington Watch
HRSA Reopens Comment Period on 340B CMP Proposed Rule
On April 19, 2016, the Health Resources and Services Administration (HRSA) is publishing a notice reopening for 30 days the comment period on its June 17, 2015 proposed rule entitled…
Health Industry Washington Watch
MedPAC Releases Annual Recommendations to Congress on Medicare Policy
The Medicare Payment Advisory Commission (MedPAC) has released its annual recommendations to Congress on Medicare policies, including Medicare fee-for-service (FFS) payment updates and a status report on the Medicare Advantage and…
To Be or Not to 340B Blog
Key Takeaway from 340B Conferences – Audits
By Alyce Katayama, Elizabeth Gebarski
Yep. Audits. They are happening. And, chances are, if your covered entity (“CE”) hasn’t experienced one yet, it is coming to you sometime soon. At both 340B University (hosted by Apexus, the…
To Be or Not to 340B Blog
Comparing 340B University and the 340B Coalition Conference
By Alyce Katayama, Elizabeth Gebarski
Maybe it is just us, but we wanted to know whether we would get a different experience at 340B University versus the 340B Coalition Conference. In some ways, these conferences…
To Be or Not to 340B Blog
Top Takeaway from 340B University and 340B Coalition Conference
By Alyce Katayama, Elizabeth Gebarski
This year we once again had boots on the ground for 340B University and the 340B Winter Coalition Conference for a four-day 340B Drug Pricing Program (340B Program) adventure. 340B University…
Health Law Update
Our 10 Most Popular Blog Posts of 2015
Out-of-network billing practices, the Medicare SGR fix, Stark Law policy changes, the “Tuomey” judgment, 21st Century Cures legislation, Part D policy changes, the two-midnight rule, regulation of Medicaid managed care,…